Truist raised the firm’s price target on Intuitive Surgical (ISRG) to $620 from $525 and keeps a Buy rating on the shares. The company delivered a second consecutive quarter of above 20% revenue and EPS growth, accelerating from Q2, behind a strong beat on almost all key metrics, including boxes, procedures, and utilization, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $575 from $520 at Mizuho
- Intuitive Surgical: Balancing Growth Potential with Market Challenges – Hold Rating Maintained
- Intuitive Surgical price target raised to $625 from $615 at RBC Capital
- Intuitive Surgical price target raised to $603 from $592 at Raymond James
- Intuitive Surgical price target raised to $655 from $536 at Baird